Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors vs sulfonylureas in patients with type 2 diabetes

Authors

Yan Xie, Saint Louis University
Benjamin Bowe, Saint Louis University
Andrew K Gibson, VA St Louis Health Care System
Janet B McGill, Washington University School of Medicine in St. Louis
Geetha Maddukuri, VA St Louis Health Care System
Ziyad Al-Aly, Washington University School of Medicine in St. Louis

Journal

JAMA Internal Medicine

Publication Date

8-1-2021

Volume

181

Issue

8

First Page

1043

Last Page

1053

Document Type

Open Access Publication

DOI

10.1001/jamainternmed.2021.2488

Rights and Permissions

Xie Y, Bowe B, Gibson AK, McGill JB, Maddukuri G, Al-Aly Z. Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes. JAMA Intern Med. 2021;181(8):1043–1053. doi:10.1001/jamainternmed.2021.2488. This is an open access article distributed under the terms of the CC-BY License. © 2021 Xie Y et al. JAMA Internal Medicine.

Recommended Citation

Xie, Yan; Bowe, Benjamin; Gibson, Andrew K; McGill, Janet B; Maddukuri, Geetha; and Al-Aly, Ziyad, "Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors vs sulfonylureas in patients with type 2 diabetes." JAMA Internal Medicine. 181, 8. 1043 - 1053. (2021).
https://digitalcommons.wustl.edu/oa_4/2832

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.